Sales Rep Wrote Out Side Effect Grades for Doctors in SIGN Trial: Panel

Third-Party Panel Members at Press Conference A sales representative of Novartis Pharma filled out side effect grading sheets on behalf of doctors in an investigator-initiated clinical trial on chronic myeloid leukemia (CML) drugs including its Tasigna (nilotinib), yet no falsification...read more